Dr. Joseph Steven Bondi, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 115 W. Fourth St., Monon, IN 47959 Phone: 219-253-6512 |
News Archive
The U.S Senate's plan to replace Obamacare, now in limbo, would cut funding for Medicaid and other health insurance subsidies by more than $1 billion a year within five years.
ZIOPHARM Oncology, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for Application Serial No. 11/257,766 entitled "Salts of Isophosphoramide mustard and analogs thereof as anti-tumor agents" with claims directed to compounds, pharmaceutical compositions, and lyophilisates. These claims cover the Company's proprietary palifosfamide composition (ZIO-201 or ZymafosTM). The Company has recently reported positive randomized Phase II sarcoma interim data for intravenous palifosfamide at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) on November 6, 2009 and expects, following U.S. Food and Drug Administration (FDA) review, to initiate a registration trial the first half of 2010.
While refining ways to grow arterial endothelial cells in the lab, a regenerative biology team at the Morgridge Institute for Research at the University of Wisconsin-Madison unexpectedly unearthed a powerful new model for studying a hallmark of vascular disease.
A Stony Brook University-led international team of infectious disease researchers have discovered how a cellular protein, called STAT3, which is overactive in a majority of human cancers, interferes with an antitumor mechanism in cells and therefore promotes the growth of cancer.
The neurosurgery residency training program at UCLA has successfully introduced digital and mobile technology—including tablet computers linked to a digital library of resources—to make neurosurgical training more effective and efficient, according to an article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
› Verified 1 days ago